Global Valsartan Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Valsartan Drug market size was valued at USD 606.1 million in 2023 and is forecast to a readjusted size of USD 918.8 million by 2030 with a CAGR of 6.1% during review period.
Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Valsartan Drug industry chain, the market status of Hypertension (40 mg Tablets, 80 mg Tablets), Heart Failure (40 mg Tablets, 80 mg Tablets), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Valsartan Drug.
Regionally, the report analyzes the Valsartan Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Valsartan Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Valsartan Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Valsartan Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 40 mg Tablets, 80 mg Tablets).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Valsartan Drug market.
Regional Analysis: The report involves examining the Valsartan Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Valsartan Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Valsartan Drug:
Company Analysis: Report covers individual Valsartan Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Valsartan Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hypertension, Heart Failure).
Technology Analysis: Report covers specific technologies relevant to Valsartan Drug. It assesses the current state, advancements, and potential future developments in Valsartan Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Valsartan Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Valsartan Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Valsartan Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Valsartan Drug, with price, sales, revenue and global market share of Valsartan Drug from 2019 to 2024.
Chapter 3, the Valsartan Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Valsartan Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Valsartan Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Valsartan Drug.
Chapter 14 and 15, to describe Valsartan Drug sales channel, distributors, customers, research findings and conclusion.
Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Valsartan Drug industry chain, the market status of Hypertension (40 mg Tablets, 80 mg Tablets), Heart Failure (40 mg Tablets, 80 mg Tablets), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Valsartan Drug.
Regionally, the report analyzes the Valsartan Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Valsartan Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Valsartan Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Valsartan Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 40 mg Tablets, 80 mg Tablets).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Valsartan Drug market.
Regional Analysis: The report involves examining the Valsartan Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Valsartan Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Valsartan Drug:
Company Analysis: Report covers individual Valsartan Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Valsartan Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hypertension, Heart Failure).
Technology Analysis: Report covers specific technologies relevant to Valsartan Drug. It assesses the current state, advancements, and potential future developments in Valsartan Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Valsartan Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Valsartan Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- 40 mg Tablets
- 80 mg Tablets
- 160 mg Tablets
- 320 mg Tablets
- Hypertension
- Heart Failure
- Heart Attack
- Novartis
- Sun Pharmaceutical
- Teva
- Mylan
- Alembic Pharmaceuticals
- Lupin
- Aurobindo Pharma
- Macleods Pharmaceuticals
- HETERO
- Torrent Pharmaceuticals
- Huaren Pharmaceutical
- Jubilant Pharma
- Amneal Pharmaceuticals
- Zhejiang Huahai Pharmaceutical
- Square Pharmaceuticals
- Unichem Laboratories
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Valsartan Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Valsartan Drug, with price, sales, revenue and global market share of Valsartan Drug from 2019 to 2024.
Chapter 3, the Valsartan Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Valsartan Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Valsartan Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Valsartan Drug.
Chapter 14 and 15, to describe Valsartan Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Valsartan Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Valsartan Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 40 mg Tablets
1.3.3 80 mg Tablets
1.3.4 160 mg Tablets
1.3.5 320 mg Tablets
1.4 Market Analysis by Application
1.4.1 Overview: Global Valsartan Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hypertension
1.4.3 Heart Failure
1.4.4 Heart Attack
1.5 Global Valsartan Drug Market Size & Forecast
1.5.1 Global Valsartan Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Valsartan Drug Sales Quantity (2019-2030)
1.5.3 Global Valsartan Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Valsartan Drug Product and Services
2.1.4 Novartis Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments/Updates
2.2 Sun Pharmaceutical
2.2.1 Sun Pharmaceutical Details
2.2.2 Sun Pharmaceutical Major Business
2.2.3 Sun Pharmaceutical Valsartan Drug Product and Services
2.2.4 Sun Pharmaceutical Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sun Pharmaceutical Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Valsartan Drug Product and Services
2.3.4 Teva Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Valsartan Drug Product and Services
2.4.4 Mylan Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Mylan Recent Developments/Updates
2.5 Alembic Pharmaceuticals
2.5.1 Alembic Pharmaceuticals Details
2.5.2 Alembic Pharmaceuticals Major Business
2.5.3 Alembic Pharmaceuticals Valsartan Drug Product and Services
2.5.4 Alembic Pharmaceuticals Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Alembic Pharmaceuticals Recent Developments/Updates
2.6 Lupin
2.6.1 Lupin Details
2.6.2 Lupin Major Business
2.6.3 Lupin Valsartan Drug Product and Services
2.6.4 Lupin Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Lupin Recent Developments/Updates
2.7 Aurobindo Pharma
2.7.1 Aurobindo Pharma Details
2.7.2 Aurobindo Pharma Major Business
2.7.3 Aurobindo Pharma Valsartan Drug Product and Services
2.7.4 Aurobindo Pharma Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Aurobindo Pharma Recent Developments/Updates
2.8 Macleods Pharmaceuticals
2.8.1 Macleods Pharmaceuticals Details
2.8.2 Macleods Pharmaceuticals Major Business
2.8.3 Macleods Pharmaceuticals Valsartan Drug Product and Services
2.8.4 Macleods Pharmaceuticals Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Macleods Pharmaceuticals Recent Developments/Updates
2.9 HETERO
2.9.1 HETERO Details
2.9.2 HETERO Major Business
2.9.3 HETERO Valsartan Drug Product and Services
2.9.4 HETERO Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 HETERO Recent Developments/Updates
2.10 Torrent Pharmaceuticals
2.10.1 Torrent Pharmaceuticals Details
2.10.2 Torrent Pharmaceuticals Major Business
2.10.3 Torrent Pharmaceuticals Valsartan Drug Product and Services
2.10.4 Torrent Pharmaceuticals Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Torrent Pharmaceuticals Recent Developments/Updates
2.11 Huaren Pharmaceutical
2.11.1 Huaren Pharmaceutical Details
2.11.2 Huaren Pharmaceutical Major Business
2.11.3 Huaren Pharmaceutical Valsartan Drug Product and Services
2.11.4 Huaren Pharmaceutical Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Huaren Pharmaceutical Recent Developments/Updates
2.12 Jubilant Pharma
2.12.1 Jubilant Pharma Details
2.12.2 Jubilant Pharma Major Business
2.12.3 Jubilant Pharma Valsartan Drug Product and Services
2.12.4 Jubilant Pharma Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Jubilant Pharma Recent Developments/Updates
2.13 Amneal Pharmaceuticals
2.13.1 Amneal Pharmaceuticals Details
2.13.2 Amneal Pharmaceuticals Major Business
2.13.3 Amneal Pharmaceuticals Valsartan Drug Product and Services
2.13.4 Amneal Pharmaceuticals Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Amneal Pharmaceuticals Recent Developments/Updates
2.14 Zhejiang Huahai Pharmaceutical
2.14.1 Zhejiang Huahai Pharmaceutical Details
2.14.2 Zhejiang Huahai Pharmaceutical Major Business
2.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Product and Services
2.14.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
2.15 Square Pharmaceuticals
2.15.1 Square Pharmaceuticals Details
2.15.2 Square Pharmaceuticals Major Business
2.15.3 Square Pharmaceuticals Valsartan Drug Product and Services
2.15.4 Square Pharmaceuticals Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Square Pharmaceuticals Recent Developments/Updates
2.16 Unichem Laboratories
2.16.1 Unichem Laboratories Details
2.16.2 Unichem Laboratories Major Business
2.16.3 Unichem Laboratories Valsartan Drug Product and Services
2.16.4 Unichem Laboratories Valsartan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Unichem Laboratories Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VALSARTAN DRUG BY MANUFACTURER
3.1 Global Valsartan Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Valsartan Drug Revenue by Manufacturer (2019-2024)
3.3 Global Valsartan Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Valsartan Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Valsartan Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Valsartan Drug Manufacturer Market Share in 2023
3.5 Valsartan Drug Market: Overall Company Footprint Analysis
3.5.1 Valsartan Drug Market: Region Footprint
3.5.2 Valsartan Drug Market: Company Product Type Footprint
3.5.3 Valsartan Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Valsartan Drug Market Size by Region
4.1.1 Global Valsartan Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Valsartan Drug Consumption Value by Region (2019-2030)
4.1.3 Global Valsartan Drug Average Price by Region (2019-2030)
4.2 North America Valsartan Drug Consumption Value (2019-2030)
4.3 Europe Valsartan Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Valsartan Drug Consumption Value (2019-2030)
4.5 South America Valsartan Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Valsartan Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Valsartan Drug Sales Quantity by Type (2019-2030)
5.2 Global Valsartan Drug Consumption Value by Type (2019-2030)
5.3 Global Valsartan Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Valsartan Drug Sales Quantity by Application (2019-2030)
6.2 Global Valsartan Drug Consumption Value by Application (2019-2030)
6.3 Global Valsartan Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Valsartan Drug Sales Quantity by Type (2019-2030)
7.2 North America Valsartan Drug Sales Quantity by Application (2019-2030)
7.3 North America Valsartan Drug Market Size by Country
7.3.1 North America Valsartan Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Valsartan Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Valsartan Drug Sales Quantity by Type (2019-2030)
8.2 Europe Valsartan Drug Sales Quantity by Application (2019-2030)
8.3 Europe Valsartan Drug Market Size by Country
8.3.1 Europe Valsartan Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Valsartan Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Valsartan Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Valsartan Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Valsartan Drug Market Size by Region
9.3.1 Asia-Pacific Valsartan Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Valsartan Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Valsartan Drug Sales Quantity by Type (2019-2030)
10.2 South America Valsartan Drug Sales Quantity by Application (2019-2030)
10.3 South America Valsartan Drug Market Size by Country
10.3.1 South America Valsartan Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Valsartan Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Valsartan Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Valsartan Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Valsartan Drug Market Size by Country
11.3.1 Middle East & Africa Valsartan Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Valsartan Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Valsartan Drug Market Drivers
12.2 Valsartan Drug Market Restraints
12.3 Valsartan Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Valsartan Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Valsartan Drug
13.3 Valsartan Drug Production Process
13.4 Valsartan Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Valsartan Drug Typical Distributors
14.3 Valsartan Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Valsartan Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Valsartan Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Valsartan Drug Product and Services
Table 6. Novartis Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Novartis Recent Developments/Updates
Table 8. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Sun Pharmaceutical Major Business
Table 10. Sun Pharmaceutical Valsartan Drug Product and Services
Table 11. Sun Pharmaceutical Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sun Pharmaceutical Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva Valsartan Drug Product and Services
Table 16. Teva Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Teva Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Valsartan Drug Product and Services
Table 21. Mylan Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Mylan Recent Developments/Updates
Table 23. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Alembic Pharmaceuticals Major Business
Table 25. Alembic Pharmaceuticals Valsartan Drug Product and Services
Table 26. Alembic Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Alembic Pharmaceuticals Recent Developments/Updates
Table 28. Lupin Basic Information, Manufacturing Base and Competitors
Table 29. Lupin Major Business
Table 30. Lupin Valsartan Drug Product and Services
Table 31. Lupin Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Lupin Recent Developments/Updates
Table 33. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Aurobindo Pharma Major Business
Table 35. Aurobindo Pharma Valsartan Drug Product and Services
Table 36. Aurobindo Pharma Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Aurobindo Pharma Recent Developments/Updates
Table 38. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Macleods Pharmaceuticals Major Business
Table 40. Macleods Pharmaceuticals Valsartan Drug Product and Services
Table 41. Macleods Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Macleods Pharmaceuticals Recent Developments/Updates
Table 43. HETERO Basic Information, Manufacturing Base and Competitors
Table 44. HETERO Major Business
Table 45. HETERO Valsartan Drug Product and Services
Table 46. HETERO Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. HETERO Recent Developments/Updates
Table 48. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Torrent Pharmaceuticals Major Business
Table 50. Torrent Pharmaceuticals Valsartan Drug Product and Services
Table 51. Torrent Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Torrent Pharmaceuticals Recent Developments/Updates
Table 53. Huaren Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Huaren Pharmaceutical Major Business
Table 55. Huaren Pharmaceutical Valsartan Drug Product and Services
Table 56. Huaren Pharmaceutical Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Huaren Pharmaceutical Recent Developments/Updates
Table 58. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 59. Jubilant Pharma Major Business
Table 60. Jubilant Pharma Valsartan Drug Product and Services
Table 61. Jubilant Pharma Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Jubilant Pharma Recent Developments/Updates
Table 63. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Amneal Pharmaceuticals Major Business
Table 65. Amneal Pharmaceuticals Valsartan Drug Product and Services
Table 66. Amneal Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Amneal Pharmaceuticals Recent Developments/Updates
Table 68. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Zhejiang Huahai Pharmaceutical Major Business
Table 70. Zhejiang Huahai Pharmaceutical Valsartan Drug Product and Services
Table 71. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 73. Square Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Square Pharmaceuticals Major Business
Table 75. Square Pharmaceuticals Valsartan Drug Product and Services
Table 76. Square Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Square Pharmaceuticals Recent Developments/Updates
Table 78. Unichem Laboratories Basic Information, Manufacturing Base and Competitors
Table 79. Unichem Laboratories Major Business
Table 80. Unichem Laboratories Valsartan Drug Product and Services
Table 81. Unichem Laboratories Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Unichem Laboratories Recent Developments/Updates
Table 83. Global Valsartan Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 84. Global Valsartan Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 85. Global Valsartan Drug Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 86. Market Position of Manufacturers in Valsartan Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 87. Head Office and Valsartan Drug Production Site of Key Manufacturer
Table 88. Valsartan Drug Market: Company Product Type Footprint
Table 89. Valsartan Drug Market: Company Product Application Footprint
Table 90. Valsartan Drug New Market Entrants and Barriers to Market Entry
Table 91. Valsartan Drug Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Valsartan Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 93. Global Valsartan Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 94. Global Valsartan Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Global Valsartan Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 96. Global Valsartan Drug Average Price by Region (2019-2024) & (USD/Unit)
Table 97. Global Valsartan Drug Average Price by Region (2025-2030) & (USD/Unit)
Table 98. Global Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 99. Global Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 100. Global Valsartan Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Global Valsartan Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Global Valsartan Drug Average Price by Type (2019-2024) & (USD/Unit)
Table 103. Global Valsartan Drug Average Price by Type (2025-2030) & (USD/Unit)
Table 104. Global Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Global Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Global Valsartan Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 107. Global Valsartan Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 108. Global Valsartan Drug Average Price by Application (2019-2024) & (USD/Unit)
Table 109. Global Valsartan Drug Average Price by Application (2025-2030) & (USD/Unit)
Table 110. North America Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 111. North America Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 112. North America Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 113. North America Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 114. North America Valsartan Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 115. North America Valsartan Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 116. North America Valsartan Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 117. North America Valsartan Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Europe Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Europe Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Europe Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 121. Europe Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 122. Europe Valsartan Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 123. Europe Valsartan Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 124. Europe Valsartan Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Valsartan Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 127. Asia-Pacific Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 128. Asia-Pacific Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 129. Asia-Pacific Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 130. Asia-Pacific Valsartan Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 131. Asia-Pacific Valsartan Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 132. Asia-Pacific Valsartan Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 133. Asia-Pacific Valsartan Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 134. South America Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 135. South America Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 136. South America Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 137. South America Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 138. South America Valsartan Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 139. South America Valsartan Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 140. South America Valsartan Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 141. South America Valsartan Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Middle East & Africa Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 143. Middle East & Africa Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 144. Middle East & Africa Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 145. Middle East & Africa Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 146. Middle East & Africa Valsartan Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 147. Middle East & Africa Valsartan Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 148. Middle East & Africa Valsartan Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Middle East & Africa Valsartan Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 150. Valsartan Drug Raw Material
Table 151. Key Manufacturers of Valsartan Drug Raw Materials
Table 152. Valsartan Drug Typical Distributors
Table 153. Valsartan Drug Typical Customers
Table 1. Global Valsartan Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Valsartan Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Valsartan Drug Product and Services
Table 6. Novartis Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Novartis Recent Developments/Updates
Table 8. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Sun Pharmaceutical Major Business
Table 10. Sun Pharmaceutical Valsartan Drug Product and Services
Table 11. Sun Pharmaceutical Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sun Pharmaceutical Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva Valsartan Drug Product and Services
Table 16. Teva Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Teva Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Valsartan Drug Product and Services
Table 21. Mylan Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Mylan Recent Developments/Updates
Table 23. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Alembic Pharmaceuticals Major Business
Table 25. Alembic Pharmaceuticals Valsartan Drug Product and Services
Table 26. Alembic Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Alembic Pharmaceuticals Recent Developments/Updates
Table 28. Lupin Basic Information, Manufacturing Base and Competitors
Table 29. Lupin Major Business
Table 30. Lupin Valsartan Drug Product and Services
Table 31. Lupin Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Lupin Recent Developments/Updates
Table 33. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Aurobindo Pharma Major Business
Table 35. Aurobindo Pharma Valsartan Drug Product and Services
Table 36. Aurobindo Pharma Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Aurobindo Pharma Recent Developments/Updates
Table 38. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Macleods Pharmaceuticals Major Business
Table 40. Macleods Pharmaceuticals Valsartan Drug Product and Services
Table 41. Macleods Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Macleods Pharmaceuticals Recent Developments/Updates
Table 43. HETERO Basic Information, Manufacturing Base and Competitors
Table 44. HETERO Major Business
Table 45. HETERO Valsartan Drug Product and Services
Table 46. HETERO Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. HETERO Recent Developments/Updates
Table 48. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Torrent Pharmaceuticals Major Business
Table 50. Torrent Pharmaceuticals Valsartan Drug Product and Services
Table 51. Torrent Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Torrent Pharmaceuticals Recent Developments/Updates
Table 53. Huaren Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Huaren Pharmaceutical Major Business
Table 55. Huaren Pharmaceutical Valsartan Drug Product and Services
Table 56. Huaren Pharmaceutical Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Huaren Pharmaceutical Recent Developments/Updates
Table 58. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 59. Jubilant Pharma Major Business
Table 60. Jubilant Pharma Valsartan Drug Product and Services
Table 61. Jubilant Pharma Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Jubilant Pharma Recent Developments/Updates
Table 63. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Amneal Pharmaceuticals Major Business
Table 65. Amneal Pharmaceuticals Valsartan Drug Product and Services
Table 66. Amneal Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Amneal Pharmaceuticals Recent Developments/Updates
Table 68. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Zhejiang Huahai Pharmaceutical Major Business
Table 70. Zhejiang Huahai Pharmaceutical Valsartan Drug Product and Services
Table 71. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 73. Square Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Square Pharmaceuticals Major Business
Table 75. Square Pharmaceuticals Valsartan Drug Product and Services
Table 76. Square Pharmaceuticals Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Square Pharmaceuticals Recent Developments/Updates
Table 78. Unichem Laboratories Basic Information, Manufacturing Base and Competitors
Table 79. Unichem Laboratories Major Business
Table 80. Unichem Laboratories Valsartan Drug Product and Services
Table 81. Unichem Laboratories Valsartan Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Unichem Laboratories Recent Developments/Updates
Table 83. Global Valsartan Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 84. Global Valsartan Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 85. Global Valsartan Drug Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 86. Market Position of Manufacturers in Valsartan Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 87. Head Office and Valsartan Drug Production Site of Key Manufacturer
Table 88. Valsartan Drug Market: Company Product Type Footprint
Table 89. Valsartan Drug Market: Company Product Application Footprint
Table 90. Valsartan Drug New Market Entrants and Barriers to Market Entry
Table 91. Valsartan Drug Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Valsartan Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 93. Global Valsartan Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 94. Global Valsartan Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Global Valsartan Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 96. Global Valsartan Drug Average Price by Region (2019-2024) & (USD/Unit)
Table 97. Global Valsartan Drug Average Price by Region (2025-2030) & (USD/Unit)
Table 98. Global Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 99. Global Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 100. Global Valsartan Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Global Valsartan Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Global Valsartan Drug Average Price by Type (2019-2024) & (USD/Unit)
Table 103. Global Valsartan Drug Average Price by Type (2025-2030) & (USD/Unit)
Table 104. Global Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Global Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Global Valsartan Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 107. Global Valsartan Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 108. Global Valsartan Drug Average Price by Application (2019-2024) & (USD/Unit)
Table 109. Global Valsartan Drug Average Price by Application (2025-2030) & (USD/Unit)
Table 110. North America Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 111. North America Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 112. North America Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 113. North America Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 114. North America Valsartan Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 115. North America Valsartan Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 116. North America Valsartan Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 117. North America Valsartan Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Europe Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Europe Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Europe Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 121. Europe Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 122. Europe Valsartan Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 123. Europe Valsartan Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 124. Europe Valsartan Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Valsartan Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 127. Asia-Pacific Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 128. Asia-Pacific Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 129. Asia-Pacific Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 130. Asia-Pacific Valsartan Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 131. Asia-Pacific Valsartan Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 132. Asia-Pacific Valsartan Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 133. Asia-Pacific Valsartan Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 134. South America Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 135. South America Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 136. South America Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 137. South America Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 138. South America Valsartan Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 139. South America Valsartan Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 140. South America Valsartan Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 141. South America Valsartan Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 142. Middle East & Africa Valsartan Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 143. Middle East & Africa Valsartan Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 144. Middle East & Africa Valsartan Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 145. Middle East & Africa Valsartan Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 146. Middle East & Africa Valsartan Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 147. Middle East & Africa Valsartan Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 148. Middle East & Africa Valsartan Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 149. Middle East & Africa Valsartan Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 150. Valsartan Drug Raw Material
Table 151. Key Manufacturers of Valsartan Drug Raw Materials
Table 152. Valsartan Drug Typical Distributors
Table 153. Valsartan Drug Typical Customers
LIST OF FIGURES
Figure 1. Valsartan Drug Picture
Figure 2. Global Valsartan Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Valsartan Drug Consumption Value Market Share by Type in 2023
Figure 4. 40 mg Tablets Examples
Figure 5. 80 mg Tablets Examples
Figure 6. 160 mg Tablets Examples
Figure 7. 320 mg Tablets Examples
Figure 8. Global Valsartan Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Valsartan Drug Consumption Value Market Share by Application in 2023
Figure 10. Hypertension Examples
Figure 11. Heart Failure Examples
Figure 12. Heart Attack Examples
Figure 13. Global Valsartan Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Valsartan Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Valsartan Drug Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Valsartan Drug Average Price (2019-2030) & (USD/Unit)
Figure 17. Global Valsartan Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Valsartan Drug Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Valsartan Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Valsartan Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Valsartan Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Valsartan Drug Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Valsartan Drug Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Valsartan Drug Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Valsartan Drug Average Price by Type (2019-2030) & (USD/Unit)
Figure 32. Global Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Valsartan Drug Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Valsartan Drug Average Price by Application (2019-2030) & (USD/Unit)
Figure 35. North America Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Valsartan Drug Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Valsartan Drug Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Valsartan Drug Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Valsartan Drug Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Valsartan Drug Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Valsartan Drug Consumption Value Market Share by Region (2019-2030)
Figure 55. China Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Valsartan Drug Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Valsartan Drug Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Valsartan Drug Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Valsartan Drug Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Valsartan Drug Market Drivers
Figure 76. Valsartan Drug Market Restraints
Figure 77. Valsartan Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Valsartan Drug in 2023
Figure 80. Manufacturing Process Analysis of Valsartan Drug
Figure 81. Valsartan Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Valsartan Drug Picture
Figure 2. Global Valsartan Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Valsartan Drug Consumption Value Market Share by Type in 2023
Figure 4. 40 mg Tablets Examples
Figure 5. 80 mg Tablets Examples
Figure 6. 160 mg Tablets Examples
Figure 7. 320 mg Tablets Examples
Figure 8. Global Valsartan Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Valsartan Drug Consumption Value Market Share by Application in 2023
Figure 10. Hypertension Examples
Figure 11. Heart Failure Examples
Figure 12. Heart Attack Examples
Figure 13. Global Valsartan Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Valsartan Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Valsartan Drug Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Valsartan Drug Average Price (2019-2030) & (USD/Unit)
Figure 17. Global Valsartan Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Valsartan Drug Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Valsartan Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Valsartan Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Valsartan Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Valsartan Drug Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Valsartan Drug Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Valsartan Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Valsartan Drug Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Valsartan Drug Average Price by Type (2019-2030) & (USD/Unit)
Figure 32. Global Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Valsartan Drug Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Valsartan Drug Average Price by Application (2019-2030) & (USD/Unit)
Figure 35. North America Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Valsartan Drug Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Valsartan Drug Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Valsartan Drug Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Valsartan Drug Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Valsartan Drug Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Valsartan Drug Consumption Value Market Share by Region (2019-2030)
Figure 55. China Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Valsartan Drug Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Valsartan Drug Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Valsartan Drug Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Valsartan Drug Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Valsartan Drug Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Valsartan Drug Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Valsartan Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Valsartan Drug Market Drivers
Figure 76. Valsartan Drug Market Restraints
Figure 77. Valsartan Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Valsartan Drug in 2023
Figure 80. Manufacturing Process Analysis of Valsartan Drug
Figure 81. Valsartan Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
